What happens when you take verapamil with St. John's wort?
Verapamil is a non-dihydropyridine calcium channel blocker used for hypertension, angina, supraventricular tachyarrhythmias, and migraine prevention. It is heavily metabolized by CYP3A4 in the gut wall and liver, with only a small fraction of an oral dose escaping first-pass elimination to reach the bloodstream. Anything that revs up CYP3A4 production will gut its bioavailability.
St. John's wort (Hypericum perforatum) is a popular over-the-counter herbal used for low mood and mild depression. Its main active constituent, hyperforin, activates a nuclear receptor called PXR (pregnane X receptor), which in turn ramps up expression of CYP3A4 and the drug-efflux pump P-glycoprotein in the intestine and liver. The induction effect builds over about 10 to 14 days and persists for a similar period after stopping the herb.
A controlled study published in Clinical Pharmacology & Therapeutics measured what happens when healthy volunteers took St. John's wort for 14 days alongside verapamil. The result was dramatic: the area under the curve (AUC) of R-verapamil dropped by 78 percent and S-verapamil by 80 percent. Peak concentrations fell substantially as well. The drug was still being absorbed normally; it was being chewed up by the newly upregulated CYP3A4 in the gut wall before it could enter the systemic circulation.
Why is this important?
An 80 percent reduction in verapamil exposure essentially erases its therapeutic effect. If you are taking verapamil to control atrial fibrillation rate, you could see your heart rate climb back into uncontrolled territory. If you are taking it for high blood pressure, your pressure may drift up. If you are using it for cluster or migraine prevention, the protective effect can disappear. Most worrying is the situation where a patient is stable on verapamil, adds St. John's wort without telling their prescriber, and then experiences a breakthrough event — an arrhythmia, a hypertensive episode, or recurrent migraines — that gets misattributed to disease progression rather than to the herb.
The reverse situation is just as concerning: a patient on St. John's wort who is started on verapamil may appear to be a non-responder, leading the prescriber to push the dose higher and higher. If the patient then stops St. John's wort, CYP3A4 levels return to normal over 10 to 14 days, and the now-too-high verapamil dose can produce dangerous bradycardia or AV block.
What should you do?
Do not take St. John's wort and verapamil together. If you want to try St. John's wort for mood, discuss it first with the prescriber managing your verapamil and consider an alternative for your heart or migraine condition while you do so. If you are starting verapamil and have been taking St. John's wort, stop the herb and wait at least two weeks before the prescriber titrates verapamil to its effective dose. Tell your prescriber every time you start, stop, or change herbal supplements — St. John's wort is just one of many CYP3A4 inducers.
If you must continue both for some reason, expect to need substantially higher verapamil doses, and accept the safety implications of withdrawal: stopping St. John's wort while continuing the increased verapamil dose risks toxicity within two weeks. This is a brittle and unsafe situation.
Which specific products are affected?
Brand-name and generic verapamil products include Calan, Calan SR, Isoptin SR, Verelan, Verelan PM, and Covera-HS. The interaction applies regardless of immediate-release or extended-release formulation because it is the gut wall enzyme that is induced.
St. John's wort is sold under many brand names and as part of multi-ingredient mood and sleep supplements. Hyperforin content varies widely between products; products standardized to higher hyperforin content (typically 3-5 percent) produce stronger induction. Lower-hyperforin formulations cause less interaction but should still be considered unsafe with verapamil because the variability between batches is large.
The bottom line
St. John's wort and verapamil is one of the best-documented herb-drug interactions in the literature, with verapamil exposure dropping by 78-80 percent. This is a high-severity, clinically meaningful conflict, and the two should not be combined. Always disclose herbal supplement use to your prescriber, and allow at least two weeks of wash-out between stopping St. John's wort and relying on verapamil's full effect.